Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $11 Price Target

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $11 price target.

byBenzinga Newsdesk

February 7, 2023

1 minute read

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $11 price target.

Green Thumb Revenue Reaches $1B Despite What CEO Calls ‘Mind-Numbing Lack Of Progress’ In Weed Regulations

By Vuk Zdinjak

Today, 8:23 AM

Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE:GTII) revenue in 2022 reached $1 billion, a 14% increase compared to $893.6 million in 2021. Q4 2022 Financial Highlights

CSE:GTII

Analyst Ratings

Expert Ratings for NOV

By Benzinga Insights

Today, 8:23 AM

Analysts have provided the following ratings for NOV (NYSE:NOV) within the last quarter:

NOV

Mid-Afternoon Market Update: Honest Co Falls After Q2 Results; Pilgrim’s Pride Shares Jump

By Lisa Levin

Today, 8:23 AM

Toward the end of trading Friday, the Dow traded up 0.03% to 35,510.30 while the NASDAQ fell 0.02% to 14,813.66. The S&P also rose, gaining 0.09% to 4,464.72.

BIOL

Mid Penn Bancorp Q3 EPS $0.86 Up From $0.78 YoY

By Bill Haddad

Today, 8:23 AM

Mid Penn Bancorp (NASDAQ:MPB) reported quarterly earnings of $0.86 per share. This is a 10.26 percent increase over earnings of $0.78 per share from the same period last year.

MPB

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $11 Price Target

Related Posts

Green Thumb Revenue Reaches $1B Despite What CEO Calls ‘Mind-Numbing Lack Of Progress’ In Weed Regulations

Expert Ratings for NOV

Mid-Afternoon Market Update: Honest Co Falls After Q2 Results; Pilgrim’s Pride Shares Jump

Mid Penn Bancorp Q3 EPS $0.86 Up From $0.78 YoY